GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » American Oncology Network Inc (NAS:AONCW) » Definitions » Retained Earnings

American Oncology Network (American Oncology Network) Retained Earnings : $-175.59 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is American Oncology Network Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. American Oncology Network's retained earnings for the quarter that ended in Mar. 2024 was $-175.59 Mil.

American Oncology Network's quarterly retained earnings increased from Sep. 2023 ($-341.36 Mil) to Dec. 2023 ($-161.81 Mil) but then declined from Dec. 2023 ($-161.81 Mil) to Mar. 2024 ($-175.59 Mil).

American Oncology Network's annual retained earnings increased from Dec. 2021 ($23.24 Mil) to Dec. 2022 ($25.83 Mil) but then declined from Dec. 2022 ($25.83 Mil) to Dec. 2023 ($-161.81 Mil).


American Oncology Network Retained Earnings Historical Data

The historical data trend for American Oncology Network's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Oncology Network Retained Earnings Chart

American Oncology Network Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Retained Earnings
- 23.24 25.83 -161.81

American Oncology Network Quarterly Data
Dec20 Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Retained Earnings Get a 7-Day Free Trial 25.83 - -341.36 -161.81 -175.59

American Oncology Network Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


American Oncology Network  (NAS:AONCW) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


American Oncology Network (American Oncology Network) Business Description

Traded in Other Exchanges
Address
10485 NE 6th Street, Unit 3930, Bellevue, WA, USA, 98004
American Oncology Network Inc Formerly American Oncology Network LLC is an alliance of physicians and seasoned healthcare leaders who provide comprehensive oncology services through 24 oncology practices located in Arkansas, Louisiana, Indiana, Virginia, Ohio, Nevada, Iowa, Missouri, Washington, North Carolina, Michigan, Maryland, South Carolina, Arizona, and Georgia. The Company also provides expertise in drug procurement and payor contracting, along with practice diversification through centralized laboratory and pathology services, as well as specialty pharmacy services.